Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

16

Revenue 2017

Shire

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Shire's 2013 CNS, immunology and metabolic's sales performance.

Shire

Roche gets wider approval for haemophilia drug Hemlibra

Roche gets wider approval for haemophilia drug Hemlibra The broader indication means that Hemlibra can now challenge the entire range of factor VIII drugs in the marketplace – both short-acting and newer long-acting versions such as Shire’s

New Awards scheme for medical and scientific professionals

Demand for this new initiative has been strong – with entries / nominations from Novo Nordisk, BMS, Eisai, GSK, Shire, Gilead, Lundbeck, Bayer, Boehringer, Teva and more.

Bayer roll-out of haemophilia drug Jivi gathers pace

Bayer roll-out of haemophilia drug Jivi gathers pace Despite efforts to transition patients from daily injections of Factor VIII to long-acting variants which can be given every few days, such as Bayer’s own Kovaltry, Shire’s Adynovate

Shire’s bleeding disorder drug approved in Europe

Shire’s bleeding disorder drug approved in Europe Veyvondi for patients with rare disease von Willebrand disease. The European Commission (EC) has given the green light to Shire’s haemostatic disorder treatment Veyvondi, which is now set to prevent ... Andreas Busch, head of research and development

Takeda rebels take aim at Shire acquisition

Takeda rebels take aim at Shire acquisition Shareholder group concerned about $30bn debt burden. Opposition to Takeda’s yet-to-be-finalised $63bn takeover of Shire appears to be building among some shareholders in Japan. ... A small but increasingly vocal group of rebel investors – including

[ Previous 5 results ] 3 4 5 6 7 8 9 10 11 12 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Nucleus Global

Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 700 experts delivering world-class...

Latest intelligence

OPEN Health Graduates and the XP Support Group
During our graduate induction period in September 2018, we were asked to find a charity that could benefit from the expertise of the OPEN Health practices. We made the decision...
Alexander Devine Website has gone live!
As part of the OPEN Health CSR programme one of the charities we support is Alexander Devine. They are a local Children's Hospice based in Maidenhead who provide a truly...
Drug pricing and competition
Strengthening business competition and reducing anti-competitive practices
How the CMA is tackling high prices for essential drugs...

Infographics